Pharmacogenomic testing: the cost factor.

doi:10.1038/sj.tpj.6500033

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Pharmacogenomic testing: the cost factor.

The pharmacogenomics journal - 1 Jan 2001

Wedlund P J, de Leon J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Costs and Cost Analysis
Share to Genotype
Share to Patient Selection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Source

Open in PubMed

Identifiers

PMID: 11908752
DOI: 10.1038/sj.tpj.6500033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic testing: the cost factor.PMID 11908752Read ↗

Assessing the cost-effectiveness of pharmacogenomics.Semantic proximity Read ↗

The Economics of Pharmacogenomics.Semantic proximity Read ↗

Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing.Semantic proximity Read ↗

Pharmacogenetics and cost-effectiveness analysis: a two-way street.Semantic proximity Read ↗

Clinical and moral challenges of pharmacogenomics.Semantic proximity Read ↗

Pharmacogenomics: playing the odds.Semantic proximity Read ↗

Pharmacogenomics in drug development: societal and technical aspects.Semantic proximity Read ↗

Pharmacogenomics: "noninferiority" is sufficient for initial implementation.Semantic proximity Read ↗

Machine Learning Challenges in Pharmacogenomic Research.Semantic proximity Read ↗

Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?Semantic proximity Read ↗

Why pharmacogenomics? Why now?Semantic proximity Read ↗

Genomic testing in oncology to improve clinical outcomes while optimizing utilization: the evolution of diagnostic testing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.